Checked Sep 29, 2026Start a new check

What was checked

Ivermectin prevents damage caused by mRNA vaccines... blocks the entry of the spike protein... treats autoimmune diseases... is antineoplastic (against cancer)... improves immunity in cancer patients [list of 20+ claims]

Assessment summary

Inaccurate

No authoritative clinical evidence establishes that ivermectin prevents or reverses harm from mRNA vaccines. Ivermectin is not authorized for this purpose, and major medical guidance does not recommend it. Preclinical anticancer findings do not establish clinical efficacy. Current oncology sources report no robust human evidence that ivermectin treats cancer, and major oncology organizations do not endorse it as cancer therapy.

This saved result keeps its original verdict. Our current method would assess it differently, so grouped findings are not shown here. Review the model assessments below or start a new check for an updated report.

Model assessments

Assessment summary

  • The response contains multiple major claims, but the provided text does not state them precisely enough to verify individually.
  • Current evidence does not support ivermectin as a treatment for vaccine injury, autoimmune disease, cancer, or improved immunity in cancer patients; some mechanisms are only preclinical and do not establish clinical benefit.

Claims reviewed

Ivermectin prevents damage caused by mRNA vaccines.

Contradicted
No authoritative clinical evidence establishes that ivermectin prevents or reverses harm from mRNA vaccines. Ivermectin is not authorized for this purpose, and major medical guidance does not recommend it.

This claim may mislead readers without added context.

Ivermectin is antineoplastic and treats cancer.

Contradicted
Preclinical anticancer findings do not establish clinical efficacy. Current oncology sources report no robust human evidence that ivermectin treats cancer, and major oncology organizations do not endorse it as cancer therapy.

This claim may mislead readers without added context.

Ivermectin blocks the entry of spike protein.

Needs context
Some laboratory or theoretical research may examine ivermectin-related effects on viral proteins or cell processes, but this does not show that ivermectin blocks spike-protein entry in vaccinated people or prevents vaccine effects.

This claim may mislead readers without added context.

Assessment summary

  • The claims make sweeping therapeutic assertions that far exceed current clinical evidence.
  • While ivermectin shows promise in laboratory and animal studies, most claims lack human clinical validation.
  • The claim about preventing mRNA vaccine damage is particularly problematic, as it contradicts established vaccine safety data and lacks any clinical support.

Claims reviewed

Ivermectin prevents damage caused by mRNA vaccines

Contradicted
No clinical evidence supports this claim. Vaccine safety data shows mRNA vaccines have a favorable benefit-risk profile, and there is no established mechanism by which ivermectin prevents vaccine-related damage in humans.

This claim may mislead readers without added context.

Ivermectin blocks the entry of the spike protein

Needs context
Molecular docking studies suggest potential binding, but this is in vitro evidence only. The claim overstates preliminary laboratory findings without clinical validation in humans.

This claim may mislead readers without added context.

Ivermectin improves immunity in cancer patients

Can’t verify
Evidence comes from animal studies and in vitro research. No robust human clinical trials demonstrate this effect in cancer patients.

Assessment summary

  • The response mixes a few true laboratory findings with several unsupported clinical claims.
  • Some in vitro and preclinical studies show ivermectin interacts with viral proteins or has anticancer effects, but there is no reliable clinical evidence that it prevents mRNA‑vaccine 'damage', treats autoimmune diseases, or meaningfully improves cancer patient immunity.
  • Major medical agencies advise against using ivermectin for COVID‑19 or vaccine injury because clinical benefit is unproven.

Claims reviewed

Ivermectin treats autoimmune diseases

Contradicted
There is no robust clinical evidence that ivermectin is an effective treatment for autoimmune diseases; claims are not supported by randomized clinical trials or clinical guidelines.

This claim may mislead readers without added context.

Ivermectin prevents damage caused by mRNA vaccines

Contradicted
No high‑quality clinical evidence shows ivermectin prevents or treats injury from mRNA COVID‑19 vaccines, and public health agencies (FDA, CDC, WHO) do not recommend it for vaccine‑related harm.

This claim may mislead readers without added context.

Ivermectin is antineoplastic (against cancer)

Needs context
Preclinical (in vitro and some animal) studies report anticancer activity for ivermectin, but clinical evidence of safe, effective anticancer use in humans is lacking and not established by well‑powered trials.

This claim may mislead readers without added context.

Sources cited

21 sources

Share this result